98%
921
2 minutes
20
Study Objectives: To examine the association of objective and subjective sleep parameters with cognitive functioning and markers of brain morphology.
Methods: This cross-sectional study included 3360 participants (mean age: 59.5 ± 8.5 years; 51.1% female) from The Maastricht Study. Time in bed (TIB) and sleep breaks were objectively estimated using a thigh-worn accelerometer. Subjective sleep continuity was assessed via a single-item, and excessive daytime sleepiness was evaluated using the Epworth Sleepiness Scale. Cognitive testing was administered across three domains- memory, information processing speed, and executive functioning and attention. Markers of brain morphology (e.g., hippocampal volume, grey matter (GM) volume and white matter volume) were assessed with 3 Tesla magnetic resonance imaging. Linear and logistic regression analyses modelled the associations.
Results: Longer TIB (h/night) was associated with worse executive functioning and attention (Blinear = -0.052, 95%CI = -0.084 to -0.019). Categorical analyses showed that a longer TIB (≥9 h/night) was associated with worse executive functioning and attention (B = -0.088, 95%CI = -0.166 to -0.010) compared to a mid-range TIB (≥7 to <9 h/night). A curvilinear association was found between TIB and lower GM volume (Bquadratic = -0.013, 95%CI = - 0.025 to -0.001). Sleep breaks (≥2/night) were associated with worse overall cognition (B = -0.069, 95%CI = -0.124 to -0.013), information processing speed (B = -0.125, 95%CI = -0.212 to -0.039), and reduced GM volume (B = -0.068, 95%CI = -0.118 to -0.018). No significant associations were found for memory or other markers of brain morphology. Subjective sleep parameters showed no associations with cognitive functioning or markers of brain morphology.
Conclusions: Adequate and uninterrupted TIB was associated with better cognitive functioning and brain morphology.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/sleep/zsaf218 | DOI Listing |
Metab Brain Dis
September 2025
Department of Pharmacology, SVKM's Dr Bhanuben Nanavati College of Pharmacy, V.M. Road, Vile Parle (W), Mumbai, India.
This study aimed to evaluate the antidepressant potential of Nitazoxanide (NTZ), an antiprotozoal drug with known anti-inflammatory and neuroprotective properties, in a chronic unpredictable mild stress (CUMS)-induced mice model of depression. NTZ was administered at doses of 75, 150, and 300 mg/kg, and its effects were assessed through a series of behavioral tests, including the forced swim test, tail suspension test, actophotometer test, and social interaction test. NTZ treatment at 150 and 300 mg/kg significantly improved behavioral and biochemical outcomes, relieving depressive-like symptoms and restoring neurochemical balance.
View Article and Find Full Text PDFEpigenomics
September 2025
College of Physical Education, Yangzhou University, Yangzhou, China.
Background: Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder lacking objective biomarkers for early diagnosis. DNA methylation is a promising epigenetic marker, and machine learning offers a data-driven classification approach. However, few studies have examined whole-blood, genome-wide DNA methylation profiles for ASD diagnosis in school-aged children.
View Article and Find Full Text PDFRadiology
September 2025
Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, Md.
Background Elevated brain iron is a potential marker for neurodegeneration, but its role in predicting onset of mild cognitive impairment (MCI) and prospective cognitive trajectories remains unclear. Purpose To investigate how brain iron and amyloid-β (Aβ) levels, measured using quantitative susceptibility mapping (QSM) MRI and PET, help predict MCI onset and cognitive decline. Materials and Methods In this prospective study conducted between January 2015 and November 2022, cognitively unimpaired older adults underwent baseline QSM MRI.
View Article and Find Full Text PDFBioelectromagnetics
September 2025
Competence Centre of Sleep Medicine, Charité -Universitaetsmedizin Berlin, Berlin, Germany.
A new whole-body exposure facility for a randomized, double-blind, cross-over provocation study investigating possible effects of 50 Hz magnetic field exposure on sleep and markers of Alzheimer's disease has been developed and dosimetrically analyzed. The exposure facility was custom-tailored for the sleep laboratory where the study was carried out and enables magnetic flux densities of up to 30 μT with a maximum field inhomogeneity of less than ± 20%. Exposure is applied fully software-controlled and in a blinded and randomized manner.
View Article and Find Full Text PDFBioimpacts
August 2025
Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia.
Introduction: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS). CD4 CD25 Tregs, which normally suppress immune responses, exhibit impaired function in MS. Treg-derived extracellular vesicles (EVs) carry immunoregulatory proteins and miRNAs that modulate T-cell activity.
View Article and Find Full Text PDF